Matches 201 - 250 out of 297 < 1 2 3 4 5 6 >


Match Document Document Title
US20100209501 CONTROLLED RELEASE BUDESONIDE MINITABLETS  
Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises...
US20110230455 AQUEOUS-BASED PHARMACEUTICAL COMPOSITION  
An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual and which comprises: (A) a pharmaceutically effective amount of solid particles of...
US20100028442 METHODS OF THERAPEUTIC TREATMENT OF EYES  
Provided are electrokinetically-altered aqueous fluids (e.g., gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an...
US20090221543 NEW CORTICOSTEROIDS  
Nitrooxy derivatives of steroidal compounds of general formula B—X1—NO2 (I) or esters or salts thereof, wherein: B is a steroidal radical, X1 is a bivalent linking group comprising an aromatic or...
US20100209500 CONTROLLED RELEASE BUDESONIDE MINITABLETS  
Embodiments of a controlled release minitablet comprise an extended release core and an optional pH dependent delayed release coating thereon, wherein the extended release core comprises...
US20050008704 Pharmaceutical composition for solubility enhancement of hydrophobic drugs  
The present invention provides a pharmaceutical composition having enhanced solubility comprising a drug and polyethylene glycol, wherein the ratio of polyethylene glycol to drug by weight is from...
US20090233890 LOW VISCOSITY, HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTION  
Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly...
US20090306029 PROCESS FOR THE PREPARATION OF STERILE POWDERED PHARMACEUTICAL COMPOUNDS  
The invention relates to a process for the preparation of pharmaceutical powders, the process comprising: a) solubilization of the pharmaceutical compound in water or in an organic solvent at a...
US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions  
The invention relates to an oral pharmaceutical composition comprising an active agent, a macroscopically homogeneous structure and a gastro-resistant coating. The macroscopically homogeneous...
US20070135398 Process for the preparation of ciclesonide  
Provided is a process for increasing the 22R/22S epidemic ratio of ciclesonide.
US20120087957 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUSPENSIONS FOR INHALATION  
Process for preparing sterile suspensions for inhalation comprising an active ingredient insoluble in water and wherein at least 80% of the particles of said active ingredient have a diameter...
US20120258939 PHARMACEUTICAL MANUFACTURING PROCESS  
The present invention provides a method for preparing a sterile suspension of a glucocorticosteroid. The glucocorticosteroids used in the invention are preferably antiinflammatory...
US20090082314 Targeting Prodrugs for the Treatment of Gastrointestinal Diseases  
Provided herein are compounds, compositions and methods for decreasing NFκB DNA-binding activity in a patient comprising administering of a therapeutically effective amount of a compound or...
US20140371179 Methods and Compositions for Treating Esophageal Diseases  
Compositions and methods for treating esophageal diseases are disclosed. More specifically, these methods may refer to the treament of esophageal varices and eosinophilic esophagitis using an oral...
US20100261691 AMORPHOUS FORM OF AN ANTI-INFLAMMATORY COMPOUND  
The invention relates to the technical field of anti-inflammatory compounds, specifically those of a steroid nature, in particular to a new amorphous form of a nitrooxy derivative of a...
US20080053430 AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS  
The present invention relates to a propellant-free aerosol formulation which contains one or more compounds of general formula 1 wherein the groups R1, R2, R3 and X− may have the meanings...
US20120301546 ACID-RESISTANT SOFT GEL COMPOSITIONS  
The present disclosure describes a delivery device for administration of nutraceuticals or pharmaceuticals, which device contains a soft gel shell comprising a gelatin-based water soluble film...
US20050124594 Method of treatment  
This invention relates to the prophylaxis of choroidal neovascularisation in macular degeneration by the introduction of a suitable anti-inflammatory agent into the vitreous. In particular, it...
US20120258167 ORAL PHARMACEUTICAL COMPOSITION  
The present application provides a method for treating or preventing Celiac disease. In one embodiment the method comprises administering to a patient in need thereof a composition comprising...
US20080050441 Process for the preparation of solid sterile active pharmaceutical ingredient  
The present invention provides a method of preparing a packed sterile solid active pharmaceutical ingredient, in particular sterile steroids such as a glucocorticosteroid acid.
US20100048523 Compounds, Compositions and Methods for Treating Hormone-Dependent Maladies  
A composition and method of using are provided, which composition includes: at least one compound selected from the group including a compound having formula (I), a salt thereof, a prodrug...
US20110086827 COMBINATION MEDICAMENT  
The subject matter of this application relates to the combination of ciclesonide or an epimer thereof with R,R-formoterol or a salt, or a hydrate of a salt thereof.
US20090022671 TREATMENT METHODS  
Disclosed are methods of treating rhinosinusitis of the upper airway passages in patients afflicted with said disease, which comprises administering at least once-a-day to the surfaces of said...
US20150258023 MICROEMULSION & SUB-MICRON EMULSION PROCESS & COMPOSITIONS  
An oil in water microemulsion or sub-micron emulsion composition for dermal delivery of at least one pharmaceutically active ingredient, is provided. The composition includes an oil phase...
US20130296284 MICROEMULSION & SUB-MICRON EMULSION PROCESS & COMPOSITIONS  
An oil in water microemulsion or sub-micron emulsion composition for dermal delivery of at least one pharmaceutically active ingredient, is provided. The composition includes an oil phase...
US20100221213 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES  
The present invention relates to Y-shape branched PEG derivatives of formulae (I) to (IV). The present invention also relates to conjugates of these Y-shape derivatives and drug molecules,...
US20110111006 CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS  
This invention provides for biocompatible and biodegradable syringeable liquid, implantable solid, and injectable gel pharmaceutical formulations useful for the treatment of systemic and local...
US20130224123 NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER  
The present invention is directed to nanoparticulate active agent compositions comprising lysozyme as a surface stabilizer. Also encompassed by the invention are pharmaceutical compositions...
US20100267678 FLUX-ENABLING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS  
The present invention is drawn to adhesive solidifying formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent...
US20130280334 Nanostructured Gels Capable of Controlled Release of Encapsulated Agents  
Self-assembled gel compositions including a gelator, e.g., an enzyme-cleavable gelator, e.g., having a molecular weight of 2500 or less, are described. The self-assembled gel compositions can...
US20150017103 Compositions with Modulating Agents  
The present invention relates to a waterless composition and foam as a vehicle in which an active pharmaceutical or cosmetic agent, when added is stable or stabilized by or its destabilization is...
US20140296191 COMPOSITIONS OF PHARMACEUTICAL ACTIVES CONTAINING DIETHYLENE GLYCOL MONOETHYL ETHER OR OTHER ALKYL DERIVATIVES  
The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other...
US20150140093 NANOCLUSTERS COMPOSITIONS AND METHODS  
Compositions, methods of making, and methods of using nanoclusters in which the nanoclusters comprise a plurality of nanoparticles having a core of nanoparticles arranged such that the surfaces of...
US20110223203 NANOCLUSTER COMPOSITIONS AND METHODS  
Compositions, methods of making, and methods of using nanoclusters in which the nanoclusters comprise a plurality of nanoparticles having a core of nanoparticles arranged such that the surfaces of...
US20100197646 SOLVENT-BASED STERILISATION OF PHARMACEUTICALS  
A sterile composition of a pharmaceutical compound is prepared by combining solvent with a non-sterile pharmaceutical compound to form a solution and filtering to yield a sterile pharmaceutical...
US20090075960 Method of treating gaucher disease  
Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant...
US20090220583 Method and composition for treating inflammatory disorders  
There is provided homogeneous pharmaceutical compositions for the treatment of inflammatory disorders comprising an antiinflammatory and/or antihistaminic active ingredient, a polar lipid liposome...
US20140234225 METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER  
The present invention is directed to nanoparticulate active agent compositions comprising lysozyme as a surface stabilizer. Also encompassed by the invention are pharmaceutical compositions...
US20050239712 Pharmaceutically active compound  
A liver-targeting active compound having the general formula (I): wherein A is α-OH or β-OH, B is α-H or β-H, C is —H, α-OH or β-OH, or B and C together form a double bond, D is —H, α-OH or β-OH,...
US20140357600 NOVEL ESTER CONTAINING COMPOSITIONS AND METHODS  
Described herein are compositions (e.g., a pharmaceutical composition) and methods for controlling the delivery of a therapeutic agent, and their use in the treatment and/or prevention of diseases...
US20130089577 NOVEL ESTER CONTAINING COMPOSITIONS AND METHODS  
Described herein are compositions (e.g., a pharmaceutical composition) and methods for controlling the delivery of a therapeutic agent, and their use in the treatment and/or prevention of diseases...
US20100151010 MEDICAMENT IN A MULTILAYER FORM  
The invention relates to a medicament in a multilayer form, containing a) a core with a pharmaceutical agent, b) an inner coating, 50 to 95 percent by weight of which arc composed of a (co)polymer...
US20140179651 CICLESONIDE FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES  
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable...
US20110269722 PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS  
The invention provides the compounds of formula (I) or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutical compositions comprising one or more compounds of...
US20140370097 STERILE PHARMACEUTICAL COMPOSITIONS  
The present invention provides a method for the sterilization of a labile glucocorticosteroid, which method comprises heat-treating by moist heat the labile glucocorticosteroid in the form of a...
US20100255061 Posterior Segment Drug Delivery  
A therapeutic device to release a therapeutic agent comprises a porous structure coupled to a container comprising a reservoir. The reservoir comprises a volume sized to release therapeutic...
US20090163457 Compositions and methods for delivering a biologically active agent  
The invention relates to codrugs having improved properties, methods for preparing and administering them, and methods of formulating and administering the codrugs as pharmaceutical preparations....
US20100119580 SUSTAINED RELEASE DRUG DELIVERY DEVICES, METHODS OF USE, AND METHODS OF MANUFACTURING THEREOF  
A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained...
US20140274982 TOPICAL COMPOSITIONS OF FLUNISOLIDE AND METHODS OF TREATMENT  
Provided herein are compositions and methods for treating or preventing a skin disease or skin condition on the skin of a subject by administering a topical flunisolide composition comprising a...
US20110288060 APPARATUS AND PROCESS FOR PRODUCING CRYSTALS  
This invention provides an oscillating baffled reactor apparatus for preparing crystalline particles of at least one substance comprising: a reactor vessel; means for supplying a first flowing...

Matches 201 - 250 out of 297 < 1 2 3 4 5 6 >